PTCT

#2358
PTC Therapeutics, Inc. - Common Stock
73.8 5 USD
+3.94%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
73.85
73.85
Year Range
44.17
87.50
Daily Change
+3.94%
Monthly Change
+13.98%
6 month change
-11.23%
Year Change
+50.99%
Previous Close
71.0 5
Open
73.8 5
Low
73.8 5
High
73.8 5
Volume
158
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

PTC Therapeutics, Inc. - Common Stock

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.

News